Literature DB >> 12090816

Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex.

Scott E Hemby1, Stephen D Ginsberg, Brian Brunk, Steven E Arnold, John Q Trojanowski, James H Eberwine.   

Abstract

BACKGROUND: Several lines of evidence indicate the altered function of the temporal lobe, including the hippocampus and entorhinal cortex (EC), is associated with schizophrenia. We used single-cell gene expression technologies to assess coordinate changes in the expression of multiple genes, including neuronal signaling and synaptic-related markers in EC layer II stellate neurons.
METHODS: We used a single-neuron microdissection technique coupled with linear antisense RNA amplification and high density/candidate gene arrays to assess coordinate changes in gene expression. The expression and relative abundance of more than 18,000 messenger RNAs were assessed from EC layer II stellate neurons from postmortem samples of schizophrenic and age-matched control brains. Results of this initial screen were used to perform a more specific secondary messenger RNA screen for each subject.
RESULTS: Data disclosed marked differences in expression of various G-protein-coupled receptor-signaling transcripts, glutamate receptor subunits, synaptic proteins, and other transcripts. Results of secondary screening showed significant decreases in levels of G-protein subunit i(alpha)1, glutamate receptor 3, N-methyl-D-aspartate receptor 1, synaptophysin, and sensory nerve action potentials 23 and 25 in the stellate neurons of schizophrenic patients. We observed down-regulation of phospholemman (a phosphoprotein associated with anion channel formation) messenger RNA and protein levels in layer II/III stellate neurons in the population with schizophrenia.
CONCLUSIONS: These results provide a preliminary expression profile of schizophrenia in defined neuronal populations. Understanding the coordinated involvement of multiple genes in human disease provides insight into the molecular basis of the disease and offers new targets for pharmacotherapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12090816     DOI: 10.1001/archpsyc.59.7.631

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  62 in total

Review 1.  Functional genomics and psychiatric illness.

Authors:  Wendy Hasenkamp; Scott E Hemby
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

2.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Sylvia E Perez; Damianka P Getova; Bin He; Scott E Counts; Changiz Geula; Laurent Desire; Severine Coutadeur; Helene Peillon; Stephen D Ginsberg; Elliott J Mufson
Journal:  Am J Pathol       Date:  2011-12-03       Impact factor: 4.307

Review 3.  Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders.

Authors:  Julie Pongrac; Frank A Middleton; David A Lewis; Pat Levitt; Károly Mirnics
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

4.  Optimizing gene expression analysis in archival brain tissue.

Authors:  Vivianna M D Van Deerlin; Lisa H Gill; Peter T Nelson
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

5.  Neuron-specific age-related decreases in dopamine receptor subtype mRNAs.

Authors:  Scott E Hemby; John Q Trojanowski; Stephen D Ginsberg
Journal:  J Comp Neurol       Date:  2003-02-03       Impact factor: 3.215

6.  Discrete cell gene profiling of ventral tegmental dopamine neurons after acute and chronic cocaine self-administration.

Authors:  Eric Backes; Scott E Hemby
Journal:  J Pharmacol Exp Ther       Date:  2003-09-09       Impact factor: 4.030

7.  Importance of input perturbations and stochastic gene expression in the reverse engineering of genetic regulatory networks: insights from an identifiability analysis of an in silico network.

Authors:  Daniel E Zak; Gregory E Gonye; James S Schwaber; Francis J Doyle
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

Review 8.  Expression profile analysis of neurodegenerative disease: advances in specificity and resolution.

Authors:  Jason G Glanzer; Phillip G Haydon; James H Eberwine
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 9.  Methodological considerations regarding single-cell gene expression profiling for brain injury.

Authors:  Jason E Davis; James H Eberwine; David A Hinkle; Paolo G Marciano; David F Meaney; Tracy K McIntosh
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 10.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.